Despite the challenging macroeconomic environment, Evonik continues to withstand the crisis well. In the third quarter 2020, the Group reached an adjusted EBITDA of €519 million. ... MORE
Evonik has developed a new osteoconductive polyether ether ketone (PEEK) for the medical technology market that improves the fusion between the bone and the implant. ... MORE
The acquisition of Porocel gives Evonik access to catalyst rejuvenation technology and to available production capacity. ... MORE
Against the backdrop of the worldwide recession triggered by the Corona pandemic, Evonik is getting through the crisis well. ... MORE
Evonik Taiwan Ltd. is successfully representing the majority of the Evonik business. ... MORE
Evonik is one of the world’s leading specialty chemicals companies. ... MORE
Scan the QR Code to add us on Line@ ... MORE
Evonik provides more than 4,000 products. Here you can find an array of them. ... MORE
Here you can find the released news & product stories of Eovnik Taiwan. ... MORE
Here you can find the released news of Evonik Taiwan Ltd. since 2018. ... MORE
Here you can find the events held by Eovnik Taiwan. ... MORE
